We are live on ! Find out more
Pacer Advisors

Pacer Advisors Portfolio holdings

AUM $35.6B
1-Year Est. Return 18.19%
This Fund
S&P 500
This Quarter Est. Return
+6.91%
1 Year Est. Return
+18.19%
3 Year Est. Return
+46.13%
5 Year Est. Return
+70.99%
10 Year Est. Return
+394.12%
AUM
$1.43B
AUM Growth
+$297M
Cap. Flow
+$228M
Cap. Flow %
16%
Top 10 Hldgs %
15.34%
Holding
1,414
New
222
Increased
745
Reduced
184
Closed
249

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$11.4M
2
AAPL icon
Apple
AAPL
+$9.16M
3
MSFT icon
Microsoft
MSFT
+$6.62M
4
META icon
Meta Platforms (Facebook)
META
+$5.96M
5
AMZN icon
Amazon
AMZN
+$5.23M

Sector Composition

Rank Sector Weight
1 Technology 18.28%
2 Financials 14.25%
3 Healthcare 11.99%
4 Industrials 10.61%
5 Consumer Discretionary 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTMX icon
1126
CytomX Therapeutics
CTMX
$705M
$11K ﹤0.01%
+525
New +$10.9K
HVT icon
1127
Haverty Furniture Companies
HVT
$401M
$11K ﹤0.01%
499
-250
-33% -$6.02K
REX icon
1128
REX American Resources
REX
$1.46B
$11K ﹤0.01%
804
-606
-43% -$8.88K
VIVO
1129
DELISTED
Meridian Bioscience Inc
VIVO
$11K ﹤0.01%
753
-329
-30% -$4.82K
BCRX icon
1130
BioCryst Pharmaceuticals
BCRX
$2.37B
$10K ﹤0.01%
+2,100
New +$10.2K
CYTK icon
1131
Cytokinetics
CYTK
$11B
$10K ﹤0.01%
+1,250
New +$14.2K
MGNX icon
1132
MacroGenics
MGNX
$235M
$10K ﹤0.01%
+550
New +$10.3K
POWL icon
1133
Powell Industries
POWL
$8.46B
$10K ﹤0.01%
+1,020
New +$9.75K
VRA icon
1134
Vera Bradley
VRA
$105M
$10K ﹤0.01%
837
-536
-39% -$4.84K
ZUMZ icon
1135
Zumiez
ZUMZ
$320M
$10K ﹤0.01%
478
-109
-19% -$2.09K
SHOE
1136
Shoe Station Group
SHOE
$395M
$9K ﹤0.01%
+674
New +$7.81K
ACHN
1137
DELISTED
Achillion Pharmaceuticals
ACHN
$9K ﹤0.01%
+3,132
New +$11.4K
GHDX
1138
DELISTED
Genomic Health, Inc.
GHDX
$9K ﹤0.01%
+250
New +$7.97K
PERY
1139
DELISTED
Perry Ellis International Inc
PERY
$9K ﹤0.01%
344
-272
-44% -$6.49K
PDLI
1140
DELISTED
PDL BioPharma, Inc.
PDLI
$9K ﹤0.01%
+3,357
New +$10.3K
APEI icon
1141
American Public Education
APEI
$875M
$8K ﹤0.01%
305
-356
-54% -$8.29K
MTRX icon
1142
Matrix Service
MTRX
$347M
$8K ﹤0.01%
+433
New +$6.81K
KDNY
1143
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$8K ﹤0.01%
+205
New +$8.95K
DHX icon
1144
DHI Group
DHX
$166M
$7K ﹤0.01%
3,911
-1,696
-30% -$3.52K
DAKT icon
1145
Daktronics
DAKT
$941M
$6K ﹤0.01%
+704
New +$6.95K
GERN icon
1146
Geron
GERN
$911M
$6K ﹤0.01%
+3,175
New +$6.41K
HSII
1147
DELISTED
Heidrick & Struggles
HSII
$6K ﹤0.01%
+260
New +$6.09K
FRAN
1148
DELISTED
Francesca's Holdings Corporation
FRAN
$6K ﹤0.01%
71
-77
-52% -$6.47K
SPOK icon
1149
Spok Holdings
SPOK
$221M
$4K ﹤0.01%
236
-174
-42% -$2.92K
GEOS icon
1150
Geospace Technologies
GEOS
$91.6M
$2K ﹤0.01%
161
-94
-37% -$1.45K

Similar funds

Pacer Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Pacer Advisors held 1,414 positions worth $1.43B, up 26% from $1.13B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Pacer Advisors deployed $228M of net new capital in Q4 2017, opening 222 new positions and adding to 745 existing holdings. Its largest new stake was Equinor: 118,925 shares worth $2.55M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $3.14M trimmed.

  • Pacer Advisors's largest Q4 2017 buy was Equinor: 118,925 shares worth $2.55M.
  • Pacer Advisors added most to Alphabet (Google) Class A in Q4 2017, an estimated $11.4M increase.
  • Pacer Advisors's biggest Q4 2017 reduction was Alphabet (Google) Class C, cutting an estimated $3.14M.
  • Pacer Advisors fully exited Adient in Q4 2017, selling an estimated $1.67M.
  • Pacer Advisors's ten largest holdings make up 15% of its $1.43B portfolio in Q4 2017.
  • Pacer Advisors opened 222 new positions and closed 249 in Q4 2017.
  • Pacer Advisors's portfolio value rose 26% quarter-over-quarter to $1.43B.

Based on Pacer Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.